Company intelligence / Profile preview

GMD Group

Başakşehir, Istanbul, Turkey

Ownership: Private
Development stage: Other

Overview

GMD Group manufactures and markets a range of sterilized absorbable and non-absorbable surgical sutures compliant with USP & EP standards, operating in a class 10,000 clean room with robust quality assurance systems. Products include DAMACRYL 910, Damadioxanone, Damacryl Rapid, and Damacaprone, which support a variety of surgical applications. Clinical results are not applicable for devices of this type; approval is based on regulatory compliance and product quality.

Therapeutic areas: Other
Modalities: Medical deviceAbsorbable sutureNon-absorbable suture
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on GMD Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GMD Group.

Explore the full profile